Clinical investigations have demonstrated a strong correlation between high levels of TIMP-1 expression and poor prognosis or tumor growth in various malignancies, including lung cancer, brain prostate cancer, breast cancer, colon cancer, and others42–48. This evidence concerns the gene TIMP1 and breast cancer.